Stock Earnings

Question 1

What are Zenas Biopharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Zenas Biopharma Inc has a total asset of $369, Net loss of $-156

Question 2

What are the key financial ratios for ZBIO?

Accepted Answer

Zenas Biopharma Inc's Current ratio is 6.47, has a Net margin is -3,120, sales per share of $0.37.

Question 3

How is Zenas Biopharma Inc's revenue broken down by segment or geography?

Accepted Answer

Zenas Biopharma Inc largest revenue segment is Immune-based Therapies, at a revenue of 5,000,000 in the most earnings release.For geography, United States is the primary market for Zenas Biopharma Inc, at a revenue of 5,000,000.

Question 4

Is Zenas Biopharma Inc profitable?

Accepted Answer

no, according to the latest financial statements, Zenas Biopharma Inc has a net loss of $-156

Question 5

Does Zenas Biopharma Inc have any liabilities?

Accepted Answer

yes, Zenas Biopharma Inc has liability of 57

Question 6

How many outstanding shares for Zenas Biopharma Inc?

Accepted Answer

Zenas Biopharma Inc has a total outstanding shares of 41.79

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022
Revenue	15	5	50	0
Revenue Growth (YoY)	--	-90%	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	49	29	17	13
Research & Development	161	139	60	61
Operating Expenses	210	168	77	75
Other Non Operating Income (Expenses)	12	7	0	-43
Pretax Income	-189	-156	-36	-119
Income Tax Expense	0	0	0	0
Net Income	-189	-156	-37	-119
Net Income Growth	48%	322%	-69%	--
Shares Outstanding (Diluted)	42.15	13.19	39.79	39.79
Shares Change (YoY)	1%	-67%	0%	--
EPS (Diluted)	-4.5	-11.89	-0.93	-3
EPS Growth	46%	1,179%	-69%	--
Free Cash Flow	-163	-119	-30	-67
Free Cash Flow Per Share	-3.86	-9.01	-0.75	-1.68
Gross Margin	--	--	--	--
Operating Margin	-1,300%	-3,260%	-54%	0%
Profit Margin	-1,260%	-3,120%	-74%	0%
Free Cash Flow Margin	-1,086.66%	-2,380%	-60%	0%
EBITDA	-195	-163	-27	-75
EBITDA Margin	-1,300%	-3,260%	-54%	0%
D&A For EBITDA	0	0	0	0
EBIT	-195	-163	-27	-75
EBIT Margin	-1,300%	-3,260%	-54%	0%
Effective Tax Rate	0%	0%	0%	0%

Zenas Biopharma Inc (ZBIO) Price

ZBIO Stock Price Chart

ZBIO Income

Follow-Up Questions